KBKristina Bartmann

Kristina Bartmann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kristina Bartmann has a total of 45 co-authors. Here are the top co-authors by number of shared publications:

  • Ellen Fritsche

    IUF - Leibniz Research Institute for Environmental Medicine, Duesseldorf, Germany; DNTOX GmbH, Duesseldorf, Germany; Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany; SCAHT - Swiss Centre for Applied Human Toxicology, Basel, Switzerland; Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland

    5 shared publications
  • Ilka Scharkin

    IUF - Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany

    3 shared publications
  • Arif Dönmez

    IUF – Leibniz Research Institute for Environmental Medicine Düsseldorf Germany

    2 shared publications
  • David Leuthold

    Department of Ecotoxicology, Chemicals in the Environment Research Section, Helmholtz Centre for Environmental Research—UFZ , 04318 Leipzig

    2 shared publications
  • Jana Nerlich

    Carl-Ludwig-Institute of Physiology, Faculty of Medicine, Leipzig University

    2 shared publications
  • Katharina Koch

    IUF - Leibniz Research Institute for Environmental Medicine, Duesseldorf, Germany; DNTOX GmbH, Duesseldorf, Germany

    2 shared publications

Latest Publications

  • Open Access

    Functional Mapping of Neurodevelopmental Disease Pathways to Key Neurodevelopmental Processes Represented in the Developmental Neurotoxicity In Vitro Testing Battery

    by Eliska Kuchovska, Kristina Bartmann, Georgea Raad, Mats Schade, Luiz Ladeira, Arif Dönmez, Jördis Klose, Nicolai Görts, Denis Polozij, Lynn‐Christin Saborowski, et al.

    The Developmental Neurotoxicity (DNT) in vitro battery (IVB) enables efficient and human‐relevant evaluation of chemicals for DNT potential. To expand its biological applicability domain toward human disease, this study maps neurodevelopmental disorder (NDD)‐relevant signaling pathways to key neurodevelopmental processes (KNDPs) using primary human fetal neural progenitor cells (NPCs). Using pharmacological intervention, eighteen NDD pathways are assessed for their impact on seven KNDPs, namely NPC proliferation, radial glia migration, neuronal and oligodendrocyte differentiation and migration, and neurite outgrowth. In total, modulation of sixteen pathways is associated with changes in at least one KNDP. Oligodendrocyte differentiation shows the highest sensitivity (13 pathways), followed by radial glia migration (11 pathways) and NPC proliferation (9 pathways), whereas neuronal migration remains unaffected. Perturbation of the RhoA and mitochondrial complex I pathways is associated with the broadest phenotypic responses, influencing five KNDPs each, while STAT3‐ and TrkB‐related modulation falls outside the assay's applicability domain. Pathway‐KNDP associations are integrated into an exemplary interactive physiological map of human oligodendrocyte development, linking mechanistic perturbations to human‐relevant biology. Defining which NDD pathways can be functionally probed refines the DNT IVB's biological applicability domain, increases confidence in its protective power, and supports mechanistic interpretation of new approach methodology‐based DNT assessment.


  • Open Access

    Early-stage quality—late-stage confidence: Neural induction quality control as a key to reproducible MEA-based neurotoxicity assays

    by Ilka Scharkin, Jochen Dobner, Nadine Pierchala, Kristina Bartmann, Ulrike Hübenthal, Farina Bendt, Gabriele Brockerhoff, Andrea Rossi, Ellen Fritsche, Julia Tigges, et al.


  • Open Access

    Perfluorooctanesulfonic acid (PFOS) antagonizes gamma-aminobutyric acid (GABA) receptors in larval zebrafish and mammalian models

    by Renee Owen, Gabriel de Macedo, Jana Nerlich, Ilka Scharkin, Kristina Bartmann, Jonas Döbler, Beatrice Engelmann, Ulrike E Rolle-Kampczyk, David Leuthold, Sebastian Gutsfeld, et al.

    Per- and polyfluoroalkyl substances are a class of synthetic chemicals detected ubiquitously in the environment, humans, and wildlife. Perfluorooctanesulfonic acid (PFOS) is one prevalent chemical previously shown to cause adverse effects on nervous system function across in vivo and in vitro models, including dark-phase hyperactivity in larval zebrafish. The objective of this study was to evaluate the role of gamma-aminobutyric acid receptors (GABARs), GABAAR and GABABR, as mediators of dark-phase hyperactivity in PFOS-exposed larval zebrafish. Zebrafish were acutely exposed to 7.87 to 120 μM PFOS, 0.68 to 12.4 μM picrotoxin (GABAAR antagonist), 0.77 to 14.05 μM propofol (GABAAR-positive allosteric modulator), 4.4 to 80 μM saclofen (GABABR antagonist), 0.43 to 7.87 μM CGP13501 (GABABR-positive allosteric modulator), or the solvent control 0.4% dimethyl sulfoxide 60 min before behavior assessment at 5 days post fertilization. Co-exposures to positive allosteric modulators and PFOS were performed. Acute exposure to PFOS caused transient dark-phase hyperactivity. Concentration-dependent dark-phase hypoactivity was observed following acute propofol or CGP13501 exposure, in contrast to the concentration-dependent hyperactivity caused by acute picrotoxin exposure. Saclofen exposure provoked a modest reduction in dark-phase motor activity at the highest concentration tested. PFOS-induced hyperactivity was rescued to baseline activity by co-exposure to propofol or CGP13501. To assess relevance across species, electrophysiological measurements were performed in cultured mouse cortical neurons and BrainSpheres derived from human-induced pluripotent stem cells. PFOS exposure reduced GABAAR-mediated currents in mouse neurons. GABAAR- and GABABR-dependent units in BrainSphere-derived neural networks exhibited increased spiking activity following PFOS exposure. This study demonstrates that PFOS antagonizes GABARs in zebrafish, mouse, and human experimental systems. Taken together, this study supports the concept that early life-stage zebrafish can be used to rapidly identify causative mechanisms, conserved across taxa, by which xenobiotic agents alter neuroactivity.


  • Open Access

    Multi-behavioral phenotyping in zebrafish identifies a novel disruptor of non-associative learning with environmental and human relevance

    by David Leuthold, Nadia Katherine Herold, Jana Nerlich, Kristina Bartmann, Ilka Scharkin, Stefan Jens Hallermann, Nicole Schweiger, Ellen Fritsche, Tamara Tal

    The vertebrate nervous system is vulnerable to chemical toxicity and the widespread release of chemicals into the environment outstrips the capacity to assess their safety. We devised a battery of automated behavior assays in larval zebrafish ( Danio rerio ), a 3R-compliant model amenable to higher-throughput chemical screens. The battery captures stereotypical visual and acoustic behaviors including habituation, a form of non-associative learning. Known pharmacological modulators of habituation in zebrafish evoked distinct behavioral patterns. By screening chemicals positive for ex vivo N-methyl-D-aspartate receptor (NMDAR) modulation, we identified chlorophene, a biocide that caused sedation, paradoxical excitation, and reduced habituation in zebrafish. Using in silico target predictions and pharmacological interventions, we discovered that chlorophene acts via gamma-aminobutyric acid A receptors (GABAARs), a previously unknown target site. Orthogonal validation in cultured mouse cortical neurons and human stem cell-derived BrainSpheres confirmed chlorophene’s interaction with GABAARs. Together, multi-behavioral phenotyping in zebrafish can accelerate the identification of neurotoxicants and their underlying mode of action.


  • Open Access

    Biostatistics and its impact on hazard characterization using in vitro developmental neurotoxicity assays

    by Hagen Eike Keßel, Stefan Masjosthusmann, Kristina Bartmann, Jonathan Blum, Arif Dönmez, Nils Förster, Jördis Klose, Axel Mosig, Melanie Pahl, Marcel Leist, et al.

    In the field of hazard assessment, Benchmark concentrations (BMC) and their associated uncertainty are of particular interest for regulatory decision making. The BMC estimation consists of various statistical decisions to be made, which depend largely on factors such as experimental design and assay endpoint features. In current data practice, the experimenter is often responsible for the data analysis and therefore relies on statistical software without being aware about the software default settings and how they can impact the outputs of data analysis. To provide more insight into how statistical decision making can influence the outcomes of data analysis and interpretation, we have used case studies on a large dataset produced by a developmental neurotoxicity (DNT) in vitro battery (DNT IVB). Here we focused on the BMC and its confidence interval (CI) estimation, as well as on the final hazard classification. We identified five crucial statistical decisions experimenter have to face during data analysis: choice of replicate averaging, response data normalization, regression modelling, BMC and CI estimation, as well as choice of benchmark response levels. In addition, the strength of our data evaluation platform is the integration of endpoint-specific hazard classifications, including flagging systems for uncertain cases, which none of the so far existing statistical data analysis platforms provide. The insights gained in this study demonstrate how important fit-for-purpose, internationally harmonized and accepted data evaluation and analysis procedures are for an objective hazard classification.